Patents by Inventor James R. Brookeman
James R. Brookeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7805176Abstract: Method and system that provides, among other things, the capability for using hyperpolarized xenon-129 as a probe to non-invasively and non-destructively characterize important properties of certain structures or materials into which hyperpolarized xenon-129 can be introduced and wherein the xenon exists in two or more chemically-shifted states that are in exchange High-resolution MR images can be generated in a fraction of a second wherein the associated signal intensities reflect material properties that characterize the gas exchange among the different states. For example, in the human or animal lung, the system and related method can exploit the differences in gas-exchange characteristics between healthy and diseased lung tissue to generate high-resolution, high signal-to-noise cross-sectional MR images that permit non-invasive regional detection of variations in lung tissue structure with a combination of spatial and temporal resolution that is unmatched by any current imaging modality.Type: GrantFiled: March 9, 2005Date of Patent: September 28, 2010Assignee: University of Virginia Patent FoundationInventors: Kai Ruppert, John P. Mugler, III, James R. Brookeman
-
Patent number: 7174200Abstract: A system and method for using hyperpolarized noble gases together with an appropriately designed and optimized magnetic resonance imaging pulse sequence to rapidly acquire static or dynamic magnetic resonance images. The strong magnetic resonance signal from hyperpolarized gases, combined with the present magnetic resonance imaging technique, presents the opportunity for the imaging of gases with both high spatial and high temporal resolution. One potential application for such a method is the direct, dynamic visualization of gas flow, which would be extremely useful for characterizing a variety of fluid systems. In the medical field, one such system of substantial importance is the lung. The system and method provides for visualizing regional ventilatory patterns throughout the respiratory cycle with high temporal and high spatial resolution. The low sensitivity to susceptibility artifacts permits good image quality to be obtained in various orientations.Type: GrantFiled: April 12, 2002Date of Patent: February 6, 2007Assignee: University of Virginia Patent FoundationInventors: Michael Salerno, John P. Mugler, III, James R. Brookeman
-
Patent number: 7164268Abstract: A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.Type: GrantFiled: December 21, 2001Date of Patent: January 16, 2007Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, James R. Brookeman
-
Patent number: 7034533Abstract: A methodology, system and computer program product for designing and optimizing a rapid magnetic resonance imaging pulse sequence for creating images of a gas or gas-filled structure with substantially reduced diffusion-induced signal attenuation during the course of data acquisition compared to that for currently available magnetic resonance imaging techniques is disclosed. The methodology and system allows desirable combinations of image signal-to-noise ration, spatial resolution and temporal resolution to be achieved that were heretofore not possible. For example, magnetic resonance imaging of hyperpolarized noble gases, which recently has shown significant promise for several medical imaging applications, particularly imaging of the human lung, can be improved. Pulse sequences designed according to the subject methods permit signal levels to be achieved that are up to ten times higher than those possible with the gradient-echo methods now commonly used for hyperpolarized-gas imaging.Type: GrantFiled: May 14, 2003Date of Patent: April 25, 2006Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, James R. Brookeman
-
Publication number: 20040260173Abstract: A system and method for using hyperpolarized noble gases together with an appropriately designed and optimized magnetic resonance imaging pulse sequence to rapidly acquire static or dynamic magnetic resonance images. The strong magnetic resonance signal from hyperpolarized gases, combined with the present magnetic resonance imaging technique, presents the opportunity for the imaging of gases with both high spatial and high temporal resolution. One potential application for such a method is the direct, dynamic visualization of gas flow, which would be extremely useful for characterizing a variety of fluid systems. In the medical field, one such system of substantial importance is the lung. The system and method provides for visualizing regional ventilatory patterns throughout the respiratory cycle with high temporal and high spatial resolution. The low sensitivity to susceptibility artifacts permits good image quality to be obtained in various orientations.Type: ApplicationFiled: October 14, 2003Publication date: December 23, 2004Inventors: Michael Salerno, John P. Mugler III, James R. Brookeman
-
Patent number: 6775568Abstract: A method and an apparatus for using hyperpolarized xenon-129 and magnetic resonance imaging or spectroscopy as a probe to non-invasively and non-destructively characterize important properties of certain structures or materials with high spatial and temporal resolution, resulting in high-resolution magnetic resonance images wherein the associated signal intensities reflect a property of interest of at least one of the compartments. Hyperpolarized xenon-129 is introduced into two compartments between which xenon-129 can be exchanged, for example, into the blood vessels of mammal organs and the tissue of said organ or into compartments within inorganic objects. Due to chemical shift and applied magnetic field strength, the hyperpolarized xenon-129 introduced into the first compartment has a different resonant frequency from the hyperpolarized xenon-129 introduced into the second compartment.Type: GrantFiled: April 12, 2001Date of Patent: August 10, 2004Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, Kai Ruppert, James R. Brookeman
-
Publication number: 20040051527Abstract: A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.Type: ApplicationFiled: June 19, 2003Publication date: March 18, 2004Inventors: John P Mugler III, James R. Brookeman
-
Patent number: 6630126Abstract: A method of screening for pulmonary embolism uses gaseous phase polarized 129Xe which is injected directly into the vasculature of a subject. The gaseous 129Xe can be delivered in a controlled manner such that the gas substantially dissolves into the vasculature proximate to the injection site. Alternatively, the gas can be injected such that it remains as a gas in the bloodstream for a period of time (such as about 8-29 seconds). The injectable formulation of polarized 129Xe gas is presented in small quantities of (preferably isotopically enriched) hyperpolarized 129Xe and can provide high-quality vasculature MRI images or NMR spectroscopic signals with clinically useful signal resolution or intensity. One method injects the polarized 129Xe as a gas into a vein and also directs another quantity of polarized gas into the subject via inhalation. In this embodiment, the perfusion uptake allows arterial signal information and the injection (venous side) allows venous signal information.Type: GrantFiled: March 12, 2001Date of Patent: October 7, 2003Assignees: Medi-Physics, Inc., University of Virginia Patent FoundationInventors: Bastiaan Driehuys, Dennis Fujii, James R. Brookeman, Klaus D. Hagspiel
-
Publication number: 20020006382Abstract: A method of screening for pulmonary embolism uses gaseous phase polarized 129Xe which is injected directly into the vasculature of a subject. The gaseous 129Xe can be delivered in a controlled manner such that the gas substantially dissolves into the vasculature proximate to the injection site. Alternatively, the gas can be injected such that it remains as a gas in the bloodstream for a period of time (such as about 8-29 seconds). The injectable formulation of polarized 129Xe gas is presented in small quantities of (preferably isotopically enriched) hyperpolarized 129Xe and can provide high-quality vasculature MRI images or NMR spectroscopic signals with clinically useful signal resolution or intensity. One method injects the polarized 129Xe as a gas into a vein and also directs another quantity of polarized gas into the subject via inhalation. In this embodiment, the perfusion uptake allows arterial signal information and the injection (venous side) allows venous signal information.Type: ApplicationFiled: March 12, 2001Publication date: January 17, 2002Inventors: Bastiaan Driehuys, Dennis Fujii, James R. Brookeman, Klaus D. Hagspiel
-
Publication number: 20010041834Abstract: A method and an apparatus for using hyperpolarized xenon-129 and magnetic resonance imaging or spectroscopy as a probe to non-invasively and non-destructively characterize important properties of certain structures or materials with high spatial and temporal resolution, resulting in high-resolution magnetic resonance images wherein the associated signal intensities reflect a property of interest of at least one of the compartments. Hyperpolarized xenon-129 is introduced into two compartments between which xenon-129 can be exchanged, for example, into the blood vessels of mammal organs and the tissue of said organ or into compartments within inorganic objects. Due to chemical shift and applied magnetic field strength, the hyperpolarized xenon-129 introduced into the first compartment has a different resonant frequency from the hyperpolarized xenon-129 introduced into the second compartment.Type: ApplicationFiled: April 12, 2001Publication date: November 15, 2001Inventors: John P. Mugler, James R. Brookeman
-
Patent number: 5245282Abstract: A new three-dimensional (3D) MR imaging pulse sequence can produce over 100 high-resolution, high-contrast images in as little as 6 minutes of imaging time. Without additional imaging time, this same image data can be post-processed to yield high-resolution, high-contrast images in any arbitrary orientation. Thus, this new pulse sequence technique provides detailed yet comprehensive coverage. The method of this invention relates to a preparation-acquisition-recovery sequence cycle. The first step is magnetization preparation (MP) period. The MP period can emply a series of RF pulses, gradient field pulses, and/or time delays to encode the desired contrast properties in the form of longitudinal magnetization. A data acquisition period includes at least two repetitions of a gradient echo sequence to acquire data for a fraction of k-space. A magnetization recovery period is provided which allows T1 and T2 relaxation before the start of the next sequence cycle.Type: GrantFiled: June 28, 1991Date of Patent: September 14, 1993Assignee: University of Virginia Alumni Patents FoundationInventors: John P. Mugler, III, James R. Brookeman
-
Patent number: 5003979Abstract: There is disclosed an image processing, pattern recognition and computer graphics system and method for the noninvasive identification and evaluation of female breast cancer including the characteristic of the boundary thereof using multidimensional Magnetic Resonance Imaging (MRI). The system and method classifies the tissue using a Fisher linear classifier followed by a refinement to show the boundary shape and whether the surface of the carcinoma is lobulated or spiculated. The results are a high information content display which aids in the diagnosis and analysis of breast cancer and to assist in any surgical or other remedial planning. The high information content display also assists in the assessment of the effectiveness of therapies showing any reduction or increase in the size of the carcinoma.Type: GrantFiled: February 21, 1989Date of Patent: April 2, 1991Assignee: University of VirginiaInventors: Michael B. Merickel, Ann H. Adams, James R. Brookeman
-
Patent number: 4945478Abstract: There is disclosed an image processing, pattern recognition and computer graphics system and method for the noninvasive identification and evaluation of atheroscelerosis using multidimensional Magnetic Resonance Imaging (MRI). Functional information, such as plaque tissue type, is combined with structure information, represented by the 3-D vessel and plaque structure, into a single composite 3-D display. The system and method is performed with the application of unsupervised pattern recognition techniques and rapid 3-D display methods appropriate to the simultaneous display of multiple data classes. The results are a high information content display which aids in the diagnosis and analysis of the atherosclerotic disease process, and permits detailed and quantitative studies to assess the effectiveness of therapies, such as drug, exercise and dietary regimens.Type: GrantFiled: November 6, 1987Date of Patent: July 31, 1990Assignee: Center for Innovative TechnologyInventors: Michael B. Merickel, Charles S. Carman, James R. Brookeman, John P. Mugler, III, Carlos R. Ayers
-
Patent number: RE44644Abstract: A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.Type: GrantFiled: January 15, 2009Date of Patent: December 17, 2013Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, James R. Brookeman
-
Patent number: RE45725Abstract: A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.Type: GrantFiled: October 14, 2013Date of Patent: October 6, 2015Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, James R. Brookeman
-
Patent number: RE47178Abstract: A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.Type: GrantFiled: May 11, 2015Date of Patent: December 25, 2018Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, James R. Brookeman
-
Patent number: RE48347Abstract: A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.Type: GrantFiled: November 19, 2018Date of Patent: December 8, 2020Assignee: University of Virginia Patent FoundationInventors: John P. Mugler, III, James R. Brookeman